Literature DB >> 27796168

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research.

Maysaa Abdulla1, Sofia Laszlo1, Johanna Triumf2, Gustaf Hedström2, Mattias Berglund2,3, Gunilla Enblad2, Rose-Marie Amini1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27796168     DOI： 10.1080/0284186X.2016.1245863

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma.

Authors:  Jian Li; Jing Han; Yu Wang; Yunxian Mo; Jibin Li; Jin Xiang; Zhiming Li; Jianhua Zhou; Siyu Wang
Journal:  Front Oncol       Date:  2020-10-07       Impact factor: 6.244

2.  Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma.

Authors:  Peter Hollander; Rose-Marie Amini; Beatrice Ginman; Daniel Molin; Gunilla Enblad; Ingrid Glimelius
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

3.  Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.

Authors:  Maysaa Abdulla; Peter Hollander; Tatjana Pandzic; Larry Mansouri; Susanne Bram Ednersson; Per-Ola Andersson; Magnus Hultdin; Maja Fors; Martin Erlanson; Sofie Degerman; Helga Munch Petersen; Fazila Asmar; Kirsten Grønbaek; Gunilla Enblad; Lucia Cavelier; Richard Rosenquist; Rose-Marie Amini
Journal:  Am J Hematol       Date:  2019-11-07       Impact factor: 10.047
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.